These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26116429)

  • 1. A supervised adverse drug reaction signalling framework imitating Bradford Hill's causality considerations.
    Reps JM; Garibaldi JM; Aickelin U; Gibson JE; Hubbard RB
    J Biomed Inform; 2015 Aug; 56():356-68. PubMed ID: 26116429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supervised signal detection for adverse drug reactions in medication dispensing data.
    Hoang T; Liu J; Roughead E; Pratt N; Li J
    Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogy in causal inference: rethinking Austin Bradford Hill's neglected consideration.
    Weed DL
    Ann Epidemiol; 2018 May; 28(5):343-346. PubMed ID: 29609873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causality assessment in pharmacovigilance: The French method and its successive updates.
    Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
    Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bradford Hill considerations on causality: a counterfactual perspective.
    Höfler M
    Emerg Themes Epidemiol; 2005 Nov; 2():11. PubMed ID: 16269083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic approach to preclinical and clinical safety biomarker qualification incorporating Bradford Hill's principles of causality association.
    Chetty RK; Ozer JS; Lanevschi A; Schuppe-Koistinen I; McHale D; Pears JS; Vonderscher J; Sistare FD; Dieterle F
    Clin Pharmacol Ther; 2010 Aug; 88(2):260-2. PubMed ID: 20592723
    [No Abstract]   [Full Text] [Related]  

  • 7. Signalling paediatric side effects using an ensemble of simple study designs.
    Reps JM; Garibaldi JM; Aickelin U; Soria D; Gibson JE; Hubbard RB
    Drug Saf; 2014 Mar; 37(3):163-70. PubMed ID: 24550103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grouping pharmacovigilance terms with semantic distance.
    Dupuch M; Lerch M; Jamet A; Jaulent MC; Fescharek R; Grabar N
    Stud Health Technol Inform; 2011; 169():794-8. PubMed ID: 21893856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the origin of Hill's causal criteria.
    Morabia A
    Epidemiology; 1991 Sep; 2(5):367-9. PubMed ID: 1742387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria.
    Shakir SA; Layton D
    Drug Saf; 2002; 25(6):467-71. PubMed ID: 12071785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modernizing the Bradford Hill criteria for assessing causal relationships in observational data.
    Cox LA
    Crit Rev Toxicol; 2018 Sep; 48(8):682-712. PubMed ID: 30433840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MOdified NARanjo Causality Scale for ICSRs (MONARCSi): A Decision Support Tool for Safety Scientists.
    Comfort S; Dorrell D; Meireis S; Fine J
    Drug Saf; 2018 Nov; 41(11):1073-1085. PubMed ID: 29876835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feature engineering and machine learning for causality assessment in pharmacovigilance: Lessons learned from application to the FDA Adverse Event Reporting System.
    Kreimeyer K; Dang O; Spiker J; Muñoz MA; Rosner G; Ball R; Botsis T
    Comput Biol Med; 2021 Aug; 135():104517. PubMed ID: 34130003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.
    Théophile H; Arimone Y; Miremont-Salamé G; Moore N; Fourrier-Réglat A; Haramburu F; Bégaud B
    Drug Saf; 2010 Nov; 33(11):1045-54. PubMed ID: 20925441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation.
    Degelman ML; Herman KM
    Mult Scler Relat Disord; 2017 Oct; 17():207-216. PubMed ID: 29055459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of signal detection in pharmacovigilance.
    Meyboom RH; Egberts AC; Edwards IR; Hekster YA; de Koning FH; Gribnau FW
    Drug Saf; 1997 Jun; 16(6):355-65. PubMed ID: 9241490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Getting causal considerations back on the right track.
    Höfler M
    Emerg Themes Epidemiol; 2006 Jul; 3():8. PubMed ID: 16854222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GRADE approach and Bradford Hill's criteria for causation.
    Schünemann H; Hill S; Guyatt G; Akl EA; Ahmed F
    J Epidemiol Community Health; 2011 May; 65(5):392-5. PubMed ID: 20947872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SSEL-ADE: A semi-supervised ensemble learning framework for extracting adverse drug events from social media.
    Liu J; Zhao S; Wang G
    Artif Intell Med; 2018 Jan; 84():34-49. PubMed ID: 29111222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.